about
Spontaneous Clearance of Hepatitis C Virus Infection Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men.Development and validation of the HCV-MOSAIC risk score to assist testing for acute hepatitis C virus (HCV) infection in HIV-infected men who have sex with men (MSM).Colonial history and contemporary transmission shape the genetic diversity of hepatitis C virus genotype 2 in Amsterdam.Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995-2010.Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) studyFrequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff valuesPatterns of hepatitis C virus RNA levels during acute infection: the InC3 study.The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis.Fourth human parechovirus serotype.Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1bHepatitis E virus as a Cause of Acute Hepatitis in The NetherlandsHepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 StudyRisk Factors for Sexual Transmission of Hepatitis C Virus Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men: A Case-Control StudyFebrile neutropenia: significance of elaborated screening for respiratory viruses, and the comparison of different sampling methods, in neutropenic patients with hematological malignanciesThe effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infectionHepatitis C virus reinfection following treatment among people who use drugs.Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial.The hepatitis C virus nonstructural protein 3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands.Characterization of Hepatitis C Virus (HCV) Envelope Diversification from Acute to Chronic Infection within a Sexually Transmitted HCV Cluster by Using Single-Molecule, Real-Time Sequencing.Changes in HIV RNA and CD4 cell count after acute HCV infection in chronically HIV-infected individuals.Safety and antiviral activity of JTK-652: a novel HCV infection inhibitor.Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam.[Imported Zika virus infection in the Netherlands].Multiplex flow cytometry-based assay to study the breadth of antibody responses against E1E2 glycoproteins of hepatitis C virus.MSM starting preexposure prophylaxis are at risk of hepatitis C virus infection.Simultaneous detection of Entamoeba histolytica, Giardia lamblia, and Cryptosporidium parvum in fecal samples by using multiplex real-time PCR.Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection.Genetic characterization of multiple hepatitis C virus infections following acute infection in HIV-infected men who have sex with men.A comparison of 454 sequencing and clonal sequencing for the characterization of hepatitis C virus NS3 variants.Evaluation of a hepatitis C virus (HCV) antigen assay for routine HCV screening among men who have sex with men infected with HIV.Hepatitis C virus (HCV) antibody dynamics following acute HCV infection and reinfection among HIV-infected men who have sex with men.Theoretical and experimental assessment of degenerate primer tagging in ultra-deep applications of next-generation sequencing.Antiviral activity of narlaprevir combined with ritonavir and pegylated interferon in chronic hepatitis C patients.Pharmacokinetics and antiviral activity of PHX1766, a novel HCV protease inhibitor, using an accelerated Phase I study design.The potentiating effect of ribavirin on interferon in the treatment of hepatitis C: lack of evidence for ribavirin-induced viral mutagenesis.Identification of two Hepatitis C Virus isolates that failed genotyping by Versant LiPA 2.0 assay.Meta-analysis of mutations in the NS5A gene and hepatitis C virus resistance to interferon therapy: uniting discordant conclusions.Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic.Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam.Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project.
P50
Q33806629-B9027121-97E3-43B1-8ED5-FCF75F6A5893Q33822918-267DFD99-EEFC-40B4-AA00-20F820ECCE4FQ34264303-92134680-0EE9-4191-BEAF-A53FE881CCD6Q34661893-AD7FF9E0-4ACF-4F67-A0C7-31F005ED5E3EQ34785317-056C2616-21B5-4855-885B-E1A054FB1E1AQ35140038-E38B86F0-843E-49BC-B480-A1C75C918BB3Q35249648-B59CD175-0E39-4DB6-B75A-769B1FF1735CQ35698428-3A2C6368-39D1-4457-A761-72800824D360Q35792120-0879F790-D6EE-4273-A4F2-3BBAC6887C10Q35826504-A14CE600-3D72-4BB7-8EB4-92AC138BEDC6Q35913390-8C387557-D5A6-430D-B801-E80538DB3764Q36148971-1FD0DCD3-C0DE-4E30-A8E2-1CF3E0BF6498Q36334818-21A35A4A-4B42-4660-820C-B1FF77E70454Q36996637-DEE0F03A-2FE8-4683-8561-070D4DB9DDD2Q37678136-200B0099-69F4-4305-89F7-9BBF0F19C029Q38123941-32AB521A-AB4B-4254-97D4-87383F59B3A8Q38289423-B9DA3FC7-0DCC-4360-8DD0-99CCC8D913DAQ38789364-4B69E43F-850E-44B3-BB52-A87B1F9551CCQ39026171-E04AF113-8F97-4C46-91A8-70707349F10DQ39031415-578E0CF1-0E4C-4051-A9AD-1A0F956599B0Q39667358-74139598-763C-4398-A738-C09E27E1D56DQ40051022-95197918-0EC9-4600-88B5-745E558D1B7FQ40061277-B8B977BB-0453-4EB7-B6D4-BA795A31EDC9Q40064492-52C21E61-E8ED-4E85-9491-41996B193C1DQ40142685-906043B6-ABFE-42ED-B53B-6C2E8FD99155Q40638503-8DE238E3-89EE-41EF-B465-B96E41CF2E29Q40762485-74FC1D98-EF0D-4FC7-B7C2-785C4593E38EQ41061535-A9B63D1E-2D94-479A-8387-395793EAD5B3Q41374762-C10A3DF8-5DF0-4001-9A28-6ECCAD422DC4Q41589171-E2368A15-2E91-433E-85F6-11E32B548E07Q41755315-CAA69868-3D01-44E9-94FA-D90286A8C347Q42219806-697A189D-D4A0-4D9E-BFED-AAB426FACFB0Q42861794-3772208A-D865-4283-99AC-BBBF908E4300Q42977232-F0180128-9AC6-4D0E-BD5D-2CE6D7DCF87EQ42982845-9191B9B8-FC02-4E75-A295-451BC3043916Q42984712-EF383684-C701-4D85-BA12-06896656F275Q42984940-5380790F-81E4-4F4A-9EFD-A00C5898ED83Q42988800-3BEF4648-F6D4-4F06-9257-98984493E1D3Q42989819-8BFBAE4D-5D13-4814-9150-629C15962D8BQ43001228-D6718A4A-DA05-4143-84DB-10D6ECFCA05E
P50
name
Janke Schinkel
@ast
Janke Schinkel
@en
Janke Schinkel
@es
Janke Schinkel
@fr
Janke Schinkel
@nl
type
label
Janke Schinkel
@ast
Janke Schinkel
@en
Janke Schinkel
@es
Janke Schinkel
@fr
Janke Schinkel
@nl
prefLabel
Janke Schinkel
@ast
Janke Schinkel
@en
Janke Schinkel
@es
Janke Schinkel
@fr
Janke Schinkel
@nl